Jon Coleman serves as Executive Vice President and Chief Commercial Officer at Dexcom, Inc., a leading developer of innovative continuous glucose monitoring (CGM) technology. In this pivotal role, he oversees the company's global commercial strategy, including sales, marketing, market access, and customer experience across all regions. Under his leadership, Dexcom has accelerated its market penetration, expanded access to CGM solutions for people with diabetes, and driven record revenue growth, solidifying its position as a market leader in transformative diabetes management technologies. With over two decades of experience in the medical device industry, Coleman brings a proven track record of commercial excellence, particularly in diabetes care. Prior to joining Dexcom in 2021, he was Senior Vice President and President of Intensive Diabetes Therapies at Medtronic Diabetes, where he spearheaded the growth of the insulin pump and automated insulin delivery portfolio, achieving significant market share gains and launching groundbreaking products like the MiniMed 780G system. Earlier in his career, he held progressive leadership positions at Abbott Diabetes Care, including Vice President of Global Marketing and Sales, where he played a key role in commercializing the FreeStyle Libre flash glucose monitoring system, revolutionizing non-invasive glucose monitoring worldwide. Coleman's strategic vision and deep industry expertise have been instrumental in Dexcom's expansion into new markets and partnerships, such as collaborations with insulin pump manufacturers and digital health platforms. His achievements include fostering innovation in patient-centric solutions, enhancing reimbursement strategies, and scaling international operations, contributing to Dexcom's mission of improving lives through advanced glucose monitoring. A dynamic leader committed to advancing diabetes technology, Coleman continues to propel Dexcom toward sustainable growth and broader accessibility.